Humphrey Fonge

19PUBLICATIONS
56CO-AUTHORS
Molecular targetsAboriginal and Torres Strait Islander mathematical, physical and chemical sciences (excl. astronomy and cosmology)Mining engineeringPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 18, 2026
Efficacy of actinium-225-labeled fully human anti-MUC-16 radioimmunoconjugate against MUC-16-positive ovarian and pancreatic ductal adenocarcinoma xenograft models.

|Jul 15, 2026
Correction: Sekar et al. Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study. Int. J. Mol. Sci. 2021, 22, 9005.

|Apr 07, 2026
Potency and safety of novel [225Ac]Ac-labeled pertuzumab-PEGylated emtansine drug conjugate against HER2-positive breast cancer.

Jessica Pougoue Ketchemen, Alissar Monzer, Fabrice Ngoh Njotu

|Jan 16, 2026
[225Ac]Ac-labeled matuzumab is an effective radioimmunotherapeutic against EGFR-positive triple negative breast cancer.

Anjong Florence Tikum, Dede Api Fon, Fabrice Ngoh Njotu

|Dec 22, 2025
Preclinical characterization of 3p-C-DEPA-NCS and 3p-C-DEPA-TFP-PEG4 as potential Actinium-225 bifunctional chelators using DOTA-NCS and macropa-NCS as benchmarks.

Jessica Pougoue Ketchemen, Stephen Ahenkorah, Emmanuel Nwangele

|Mar 24, 2025
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Antitumor Responses in KRAS- and BRAF-Mutant Colorectal Cancer.

Anjong Florence Tikum, Nikita W Henning, Jessica Pougoue Ketchemen

Pageof 4

Frequent Collaborators

4 joint publications

Hanan Babeker

4 joint publications

Jessica Pougoue Ketchemen

3 joint publications

Alissar Monzer

3 joint publications

Anjong Florence Tikum